Literature DB >> 11765843

Treatment window for hypothermia in brain injury.

C G Markgraf1, G L Clifton, M R Moody.   

Abstract

OBJECT: The goal of this study was to evaluate the therapeutic window for hypothermia treatment following experimental brain injury by measuring edema formation and functional outcome.
METHODS: Traumatic brain injury (TBI) was produced in anesthetized rats by using cortical impact injury. Edema was measured in the ipsilateral and contralateral hemispheres by subtracting dry weight from wet weight, and neurological function was assessed using a battery of behavioral tests 24 hours after TBI. In injured rats, it was found that brain water levels were elevated at I hour postinjury, compared with those in sham-injured control animals, and that edema peaked at 24 hours and remained elevated for 4 days. Hypothermia (3 hours at 30 degrees C) induced either immediately after TBI or 60 minutes after TBI significantly reduced early neurological deficits. Delay of treatment by 90 or 120 minutes postinjury did not result in this neurological protection. Immediate administration of hypothermia also significantly decreased the peak magnitude of edema at 24 hours and 48 hours postinjury, compared with that in normothermic injured control animals. When delayed by 90 minutes, hypothermia did not affect the pattern of edema formation.
CONCLUSIONS: When hypothermia was administered immediately or 60 minutes after TBI, injured rats showed an improvement in functional outcome and a decrease in edema. Delayed hypothermia treatment had no effect on functional outcome or on edema.

Entities:  

Mesh:

Year:  2001        PMID: 11765843     DOI: 10.3171/jns.2001.95.6.0979

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  23 in total

Review 1.  [Therapeutic hypothermia].

Authors:  A Schneider; E Popp; P Teschendorf; B W Böttiger
Journal:  Anaesthesist       Date:  2008-02       Impact factor: 1.041

2.  Effects of ketamine on endotoxin and traumatic brain injury induced cytokine production in the rat.

Authors:  Jeremy L Ward; Matthew T Harting; Charles S Cox; David W Mercer
Journal:  J Trauma       Date:  2011-06

Review 3.  Management of intracranial pressure.

Authors:  Thomas J Wolfe; Michel T Torbey
Journal:  Curr Neurol Neurosci Rep       Date:  2009-11       Impact factor: 5.081

Review 4.  Coagulopathy in traumatic brain injury.

Authors:  Sherman C Stein; Douglas H Smith
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

5.  Regional differences in cerebral edema after traumatic brain injury identified by impedance analysis.

Authors:  Matthew T Harting; Carter T Smith; Ravi S Radhakrishnan; Kevin R Aroom; Pramod K Dash; Brijesh Gill; Charles S Cox
Journal:  J Surg Res       Date:  2008-11-27       Impact factor: 2.192

Review 6.  Therapeutic hypothermia and targeted temperature management in traumatic brain injury: Clinical challenges for successful translation.

Authors:  W Dalton Dietrich; Helen M Bramlett
Journal:  Brain Res       Date:  2015-12-30       Impact factor: 3.252

7.  Intra-arrest cooling with delayed reperfusion yields higher survival than earlier normothermic resuscitation in a mouse model of cardiac arrest.

Authors:  Danhong Zhao; Benjamin S Abella; David G Beiser; Jason P Alvarado; Huashan Wang; Kimm J Hamann; Terry L Vanden Hoek; Lance B Becker
Journal:  Resuscitation       Date:  2007-12-21       Impact factor: 5.262

8.  Preventing neuronal edema increases network excitability after traumatic brain injury.

Authors:  Punam A Sawant-Pokam; Tyler J Vail; Cameron S Metcalf; Jamie L Maguire; Thomas O McKean; Nick O McKean; K C Brennan
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

Review 9.  Neuroprotection Trials in Traumatic Brain Injury.

Authors:  Shamik Chakraborty; Brett Skolnick; Raj K Narayan
Journal:  Curr Neurol Neurosci Rep       Date:  2016-04       Impact factor: 5.081

Review 10.  Emerging treatments for traumatic brain injury.

Authors:  Ye Xiong; Asim Mahmood; Michael Chopp
Journal:  Expert Opin Emerg Drugs       Date:  2009-03       Impact factor: 4.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.